基本信息
浏览量:315
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
I am a urologic surgeon whose focus is on the care of patients with urologic malignancies, especially kidney tumors. Because the treatment of kidney cancer is complex and continues to evolve, I work closely with colleagues in medical oncology, radiology, and pathology to deliver the most up-to-date, multidisciplinary care. Sometimes multiple treatments can exist for these conditions, and it’s essential that patients have a thorough knowledge of their options. If surgery is the recommended treatment, my team and I will answer all the questions patients may have leading up to and recovering from surgery. I utilize open, endoscopic, and minimally invasive (robotic) treatments and tailor the approach based on each patient’s unique circumstances.
Read more
I believe that significant advances in cancer care will be made through the analysis of vast amounts of data being generated from genetic sequencing. Therefore, my laboratory research focuses on understanding the mechanisms of kidney cancer initiation and progression while utilizing these genomic approaches. For this, I work closely with computational and molecular biologists. The goals of these collaborations are to translate the discoveries we make in the lab into clinically meaningful improvements for my patients.
I have lectured and published extensively on the genomic underpinnings of kidney cancer and identified several mutations that predict more aggressive disease. For this and other work, I have received awards from the American Society of Clinical Oncology, Society of Urologic Oncology and the Kidney Cancer Association. Ultimately the goals of my clinical work and research are the same – to individualize patient care.
Clinical Expertise
Urologic Cancers; Kidney Cancer; Open and Minimally Invasive Surgery
Read more
I believe that significant advances in cancer care will be made through the analysis of vast amounts of data being generated from genetic sequencing. Therefore, my laboratory research focuses on understanding the mechanisms of kidney cancer initiation and progression while utilizing these genomic approaches. For this, I work closely with computational and molecular biologists. The goals of these collaborations are to translate the discoveries we make in the lab into clinically meaningful improvements for my patients.
I have lectured and published extensively on the genomic underpinnings of kidney cancer and identified several mutations that predict more aggressive disease. For this and other work, I have received awards from the American Society of Clinical Oncology, Society of Urologic Oncology and the Kidney Cancer Association. Ultimately the goals of my clinical work and research are the same – to individualize patient care.
Clinical Expertise
Urologic Cancers; Kidney Cancer; Open and Minimally Invasive Surgery
研究兴趣
论文共 414 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of cachexia, sarcopenia and muscleno. 2 (2024): 726-734
Lennert Eismann, Lina Posada Calderon,Mark T. Dawidek,Stephen Reese, Katiana Vazquez Rivera, Marc Ganz,Christian G. Stief,Jonathan Coleman,Ed Reznik,Paul Russo,Abraham Ari Hakimi
Lennert Eismann,Mark Zucker, Burcin Agridag, Sam Keene, Armaan Kohli,Stephen Reese,Andreas Aulitzky,Mark Dawidek,Christian Stief,Abraham Ari Hakimi,Ed Reznik,Jonathan Coleman
UROLOGY PRACTICEno. 2 (2024): 356-366
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONSno. 2 (2024): 32e9-32e16
Wesley Yip,Daniel D Sjoberg,Lucas M Nogueira,Andrew T Tracey, Ricardo G Alvim,Peter A Reisz,Quinlan Demac,Nicole E Benfante, Rand W Vanden Berg,Kwanghee Kim,Hikmat Al-Ahmadie,Oscar Lin,
The Journal of urologyno. 5 (2023): 863-871
Nature Cancerno. 7 (2023): 984-1000
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn